Patent details

EP2542060 Title: COMPOSITIONS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE

Basic Information

Publication number:
EP2542060
PCT Application Number:
US2011027218
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117514315
PCT Publication Number:
WO2011109724
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOSITIONS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE
French Title of Invention:
COMPOSITIONS POUR LE TRAITEMENT ET/OU LA PRÉVENTION DE MALADIES CARDIO-VASCULAIRES
German Title of Invention:
ZUSAMMENSETZUNGEN ZUR BEHANDLUNG UND/ODER PRÄVENTION VON HERZ-KREISLAUF-ERKRANKUNGEN
SPC Number:

Dates

Filing date:
04/03/2011
Grant date:
02/10/2019
EP Publication Date:
09/01/2013
PCT Publication Date:
09/09/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/10/2019
EP B1 Publication Date:
02/10/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/03/2020
Expiration date:
04/03/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/09/2019
 
 

Name:
Amarin Pharmaceuticals Ireland Limited
Address:
2 Pembroke House Upper Pembroke Street 28-32, Dublin 2, Ireland (IE)

Inventor

Name:
ROWE, Jonathan
Address:
United States (US)

Priority

Priority Number:
310443 P
Priority Date:
04/03/2010
Priority Country:
United States (US)

Classification

IPC classification:
A01N 37/00; A61K 9/48; A61K 31/20; A61K 31/202; A61K 31/232; A61K 45/06; A61P 3/06; A61P 9/00; A61P 9/10;

Publication

European Patent Bulletin

Issue number:
201940
Publication date:
02/10/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages